- Home
- BMMX vs ANTX Comparison
BMMX vs ANTX Comparison
Compare BMMX & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
BUY
Current Price
$3.59
Company Overview
Basic Information| Metric | BMMX | ANTX |
|---|---|---|
| Founded | 2004 | 2017 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 175.0M | 172.9M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | BMMX | ANTX |
|---|---|---|
| Price | $3.32 | $3.59 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 98.4K | ★ 306.3K |
| Earning Date | 11-27-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.56 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.13 | $1.00 |
| 52 Week High | $3.55 | $7.19 |
Technical Indicators
Market Signals| Indicator | BMMX | ANTX |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 21.92 |
| Support Level | N/A | $2.87 |
| Resistance Level | N/A | $5.21 |
| Average True Range (ATR) | 0.00 | 0.40 |
| MACD | 0.00 | -0.17 |
| Stochastic Oscillator | 0.00 | 2.34 |
Price Performance
Historical Comparison BMMX
ANTX
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.